Prognostic Biomarkers for Chagas Disease - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Prognostic Biomarkers for Chagas Disease

New research identifies metabolic signatures that could help predict which patients with Chagas disease are most likely to develop serious cardiac complications

  • November 3, 2026

  • 2 min

Share

  • 1

    Chagas disease can remain asymptomatic for decades, but 20% to 30% of chronically infected people develop clinically significant cardiac disease.

  • 2

    Researchers analyzed stored serum samples from 72 patients with chronic Chagas disease in Bolivia using liquid chromatography–mass spectrometry.

  • 3

    Among patients initially without cardiac involvement, 15 developed more advanced disease during follow-up, while 48 remained stable.

  • 4

    Eight metabolites were associated with future progression, and 10 of 45 candidate biomarker panels achieved at least 60% sensitivity and 90% specificity.

  • 5

    The biomarkers require validation in larger, geographically diverse studies, standardized testing methods, and evidence of clinical utility before routine use.

Original Source(s)

Prognostic Biomarkers for Chagas Disease

  • November 3, 2026

Related Content

Vampire bats may link Chagas cycles

Molecular screening detected Trypanosoma cruzi in 42% of sampled bats in northern Belize, raising questions about their role in parasite transmission.

FDA expands talazoparib use in prostate cancer

The combination with enzalutamide reduced the risk of radiographic progression or death by 52% .

Gold-Based Sensor Finds Bugs, Fast

New filtration technique detects low concentrations of bacteria and assesses antibiotic susceptibility, offering a potential faster route to diagnosing sepsis and other serious infections

  • October 30, 2026

  • 2 min